Max Planck Institute of Psychiatry

In frontotemporal dementia, the same brain networks can be affected as in schizophrenia

The brain uses bodily signals to regulate fear

Uncovering the activities of the organs, tissues and cells responsible for the body’s stress response revealed new cells and possible new drug targets

Cleverly combining artificial and human intelligence leads to improved prevention of psychosis in young patients

The molecule, which is increasingly formed in the brains of depressed patients, triggers fear reactions in mice

When the human body is exposed to stress, it goes into the very same emergency mode that it used in the Stone Age. However, that reaction is not nearly as well suited to our way of life today. Scientists at the Max Planck Institute of Psychiatry and the Max Planck Institute for Human Cognitive and Brain Sciences are studying what happens in the body during stress, who is particularly susceptible to stress, as well as when it is an especially bad time to have to deal with a large amount of stress.

People who run away screaming from tiny spiders are often ridiculed by their peers. But a pronounced fear of spiders is anything but funny if you’re the person affected. Florian Binder, a member of Victor Spoormaker’s research group at the Max Planck Institute of Psychiatry in Munich, is using virtual reality to gain a better understanding of anxiety disorders and to develop a standard therapy. The author tried it out on herself to find out how it works.

Just tired? Or depressed? Introverted or autistic? Imaginative or schizophrenic? The symptoms of psychiatric illnesses are not always clear. Therefore, Nikolaos Koutsouleris, a fellow at the Max Planck Institute of Psychiatry, also relies on artificial intelligence for early detection. Algorithms are designed to supplement the doctor’s expertise by detecting patterns in patients’ genetic and physiological data.

Silvia Cappello’s life is all about movement: at the Max Planck Institute of Psychiatry, she performs research into the way in which different types of neurons migrate to the correct position in the cerebral cortex, during embryonic development of the brain. In her free time, the passionate athlete rarely stands still either.

People who haven’t gotten enough sleep often see the world as a fairly sad place. If their tiredness lasts for weeks or even months, their dark mood may become chronic and develop into depression. Conversely, depression is frequently also associated with severe sleep disorders. Axel Steiger and his team at the Max Planck Institute of Psychiatry in Munich are studying the connection between disturbed sleep and depression. To do this, they measure human brain activity in the sleep lab.

The World Health Organization estimates that around 300 million people worldwide are affected by depression. Affective disorders represent one of the most significant causes for the loss of healthy life years and result in a reduced life expectancy compared to the general population. Psychotropic drugs approved for the treatment of depression do not result in disease improvement or even remission in all affected patients. The identification of specific biomarkers that provide each patient with the optimal drug would be an important milestone in personalized psychiatric medicine.

Stress-induced diseases are among the most common health problems worldwide and include both mental disorders such as depression and physical conditions such as diabetes. These diseases are causally related to each other and the mechanisms of stress regulation could be a common cause of both physical and mental disorders. We have identified a central mechanism that is decisively involved in the development of stress-induced diseases and represents a novel treatment option.

Stress can affect gene expression through epigenetic mechanisms such as DNA-methylation. New research suggests a similar regulation at the level of messenger molecules (mRNA) which are responsible for the transmission of genetic information. The most common mRNA modification N6-methyladenosine (m6A) is regulated by stress in the brain and shows a changed signature in the blood of patients suffering from depression. Future research investigating the involvement of m6A in the stress response can provide a better understanding of the origin of stress-related psychiatric disorders.

Psychiatric diseases represent one of the major public health burdens in western societies. The scientists at the Max-Planck Institute of Psychiatry are developing a new system medicine approach in order to address these challenges. In this approach, pluripotent stem cell based personalized disease models are used to generate various human brain cells in the laboratory. By combining these models with sophisticated computational analysis strategies, the scientists aim at decoding the patient specific molecular genetic basis of these diseases.

Malformations of the cerebral cortex are often associated with intellectual disability and epilepsy. These disorders arise in the course of cortical development as a consequence of disturbance of neuronal development, migration and connection. In order to develop therapeutic strategies, it is essential to understand the genetic causes and to investigate the molecular and cellular mechanisms underlying these malformations. The MPI research group uses cerebral organoids derived from induced stem cells for this purpose.